Abstract
The Drosophila lymph gland serves as an excellent model for studying blood cell development, closely mirroring the key components of mammalian hematopoietic niches: blood cell progenitors, mature blood cells, and niche cells that secrete signals to regulate progenitor maintenance. In the Drosophila larva, two primary types of mature hemocytes exist: macrophage-like plasmatocytes and platelet-like crystal cells. In cases of immune challenge or neoplastic conditions, a third type of hemocyte, the lamellocyte, appears to encapsulate large invaders that plasmatocytes cannot phagocytose. Importantly, the spontaneous appearance of lamellocytes in unchallenged larvae indicates defects in progenitor maintenance or blood cell fate regulation. In this study, we uncover a novel role for the molecular chaperone Hsc70–4 in suppressing lamellocyte differentiation across all three domains of the lymph gland. We show that Hsc70–4 depletion in the niche induces non-apoptotic cell death and oxidative stress, which in turn drives non-cell-autonomous lamellocyte differentiation via the Akt/Foxo pathway. In blood cell progenitors, particularly distal progenitors, Hsc70–4 loss promotes cell-autonomous lamellocyte differentiation, thereby diminishing the progenitor pool. Furthermore, silencing Hsc70–4 in mature hemocytes elicits a strong immune response characterized by primary lobe disintegration, lamellocyte transdifferentiation, and melanotic tumor formation. Together, these findings highlight the multifaceted roles of Hsc70–4 in Drosophila hematopoiesis, offering valuable insights that could enhance our understanding of the role of its orthologue in mammals and humans.
1 Introduction
Hematopoietic stem cells (HSCs) and blood cell precursors are maintained by intricate cell-autonomous and non-cell-autonomous signaling networks across the evolutionary spectrum, with numerous conserved mechanisms between Drosophila and humans (–). In Drosophila, the lymph gland, a multilobed hematopoietic organ, serves as a major source of larval blood cells (hemocytes). Within the primary (anterior) lobes of the lymph gland, the medullary zone (MZ) contains progenitors that differentiate into mature hemocytes that populate the cortical zone (CZ) of the lobe. At the posterior end of the primary lobes, the lymph gland harbors a hematopoietic niche (the posterior signaling center (PSC)), which emits signals to the MZ to regulate progenitor differentiation (, –). Two types of differentiated hemocytes can be distinguished in the CZ and the larval circulation: phagocytic plasmatocytes and melanin-producing cells, known as crystal cells (–). Immune challenges or defects in progenitor maintenance signals can trigger the differentiation of larger, specialized cells called lamellocytes. The primary function of lamellocytes is to encapsulate larger particles that plasmatocytes are unable to engulf, such as parasitic wasp eggs (, –). Because lamellocytes are absent under uninduced conditions, their emergence in naive animals may suggest a malfunction in the mechanisms maintaining hemocyte progenitors in the larva (, ).
Heat shock proteins (Hsps) in Drosophila are a conserved family of molecular chaperones that maintain protein homeostasis by assisting in folding, stabilization, and degradation of proteins under both physiological and stress conditions (, ). Although traditionally associated with stress responses, many Hsps, such as the Heat Shock Cognate 70 (Hsc70) proteins, are constitutively expressed and carry out essential housekeeping functions (). In a genetic screen for novel regulators of hemocyte differentiation, we identified Heat shock protein 70 cognate 4 (Hsc70-4) as a gene of interest. Hsc70–4 is the best-studied Drosophila Hsc70 member, and it is involved in diverse cellular processes, including maintenance of neuromuscular junctions (), germline stem cell differentiation (), and eye development (). Within the hematopoietic system, Hsc70–4 is expressed in both the lymph gland and circulating hemocytes, and prior studies have found that Hsc70–4 mutants develop melanotic tumors in their hemocoel (). Additionally, Hsc70–4 has been reported to be part of a chaperonin complex together with Mlf and DNAj-1, which stabilizes Lozenge (Lz), a transcription factor crucial for specifying crystal cell fate in Drosophila cell lines (, ). Despite these findings, the function of Hsc70–4 in the different lymph gland zones, and its influence on other effector hemocytes and progenitors, remain poorly understood.
In this paper, we report a previously uncharacterized role of the molecular chaperone Hsc70–4 in suppressing lamellocyte differentiation throughout all three domains of the lymph gland. Our findings demonstrate that Hsc70–4 supports progenitor maintenance via both cell-autonomous and non-cell-autonomous mechanisms. Additionally, we show its involvement in the transdifferentiation of plasmatocytes into lamellocytes in the lymph gland and circulation. Notably, silencing Hsc70–4 in differentiated hemocytes triggers primary lobe disintegration and melanotic tumor formation. Together, these findings reveal context-dependent functions of Hsc70–4 and highlight its central role in regulating Drosophila hematopoiesis.
2 Results
2.1 Hsc70–4 controls hematopoietic niche size and function in the lymph gland
In a screen aimed to identify genes whose silencing triggers lamellocyte differentiation in the larva, we identified Hsc70-4. Using two independent RNAi lines (Hsc70-4RNAi#1 [BDSC#28709] and Hsc70-4RNAi#2 [BDSC#35684]), we found that PSC-specific silencing of Hsc70–4 in the lymph gland, driven by col-Gal4, induces the differentiation of lamellocytes in the larval hematopoietic organ and their subsequent appearance in circulation (Figures 1A-C, A’-C’, quantification in Figures 1D, D’). This suggests that Hsc70–4 is required in the hematopoietic niche to suppress progenitor differentiation in a non-cell-autonomous manner.
Figure 1
Further analysis of Hsc70-4RNAi#1 (hereafter referred to as Hsc70-4RNAi) lymph glands revealed that silencing Hsc70–4 in the PSC also reduces crystal cell differentiation in the lymph gland, without significantly affecting plasmatocyte differentiation (Supplementary Figures S1A, B, D, E, quantification in Supplementary Figures S1C, F). This observation is consistent with previous experiments by our group and others suggesting that when lamellocyte differentiation is triggered in the lymph gland, the fate of crystal cells is less favored (, ).
As niche size has been shown to correlate with progenitor differentiation rates (), we investigated whether silencing Hsc70–4 impacts niche cell number. We found that both Hsc70-4RNAi lines caused a significant reduction in niche size compared to the control (Figures 1A–C, quantification in Figure 1E). Importantly, manipulation of Hsc70–4 with an alternative PSC driver, Antp-GAL4, also decreased niche size (Supplementary Figures S1G, H, quantification in Supplementary Figure S1I), further reinforcing that Hsc70–4 is essential for maintaining normal hematopoietic niche size and function in the lymph gland.
2.2 Hsc70–4 depletion in the niche causes non-apoptotic cell death of niche cells
We next sought to determine the cause of the reduced niche size observed in col>Hsc70-4RNAi lymph glands. Previous studies have shown that the Myc oncoprotein promotes niche growth downstream of Dpp and Wg signaling by stimulating cell proliferation (). To test whether Hsc70–4 depletion reduces niche size by suppressing Myc-driven cell division, we overexpressed Myc in col>Hsc70-4RNAi larvae. However, Myc overexpression failed to rescue either the reduction in niche size or the appearance of lamellocytes in the lymph gland and circulation (Figures 2A-D, A’-D’, quantification in Figures 2H, I, H’). Consistent with this, phospho-histone H3 (pH3) staining, which marks mitotic cells () showed no significant difference between col>Hsc70-4RNAi niches and controls (Figures 2J, K, quantification in Figure 2L). These results indicate that the smaller niche phenotype in col>Hsc70-4RNAi larvae is not due to impaired cell division.
Figure 2
To further assess whether Hsc70–4 silencing disrupts normal cell cycle progression, we used the FUCCI system to examine the cell cycle profile in the niche (31). Notably, most remaining PSC cells in col>Hsc70-4RNAi animals were in the G2/M phase, with a marked loss of cells in the G1 phase (Figures 2M, N, quantification in Figure 2O). To exclude the possibility that G2/M stalling in col>Hsc70-4RNAi niches accounts for the reduced niche size, we overexpressed String (Cdc25), a kinase that promotes progression through the G2 phase (32, 33). While this intervention modestly increased PSC cell number in col>Hsc70-4RNAi larvae, the PSC size remained smaller than in control col>string animals, and lamellocyte differentiation was not rescued (Figures 2E, F, E’, F’, quantification in Figures 2H, I, H’).
Collectively, these findings suggest that the reduction in niche size following Hsc70–4 depletion is not attributable to decreased cell division or a slower cell cycle. Instead, the most plausible explanation is that Hsc70–4 depletion induces niche cell death, with cells in the G1 phase being particularly vulnerable. Indeed, 7-AAD staining, which labels dead or dying cells (34), was frequently observed in the PSCs of col>Hsc70-4RNAi animals but was absent in controls (Figures 2P, Q, quantification in Figure 2R). In contrast, staining with the apoptosis marker Dcp-1 showed no significant increase in PSC apoptosis (Figures 2S, T, quantification in Figure 2U). Moreover, overexpression of the apoptosis inhibitor p35 did not rescue PSC size in col>Hsc70-4RNAi larvae (Figures 2G, G’, quantification in Figures 2H, I, H’).
Taken together, these results indicate that Hsc70–4 depletion reduces niche size not by impairing proliferation or causing apoptosis, but instead by inducing non-apoptotic cell death. Importantly, cells in the G1 phase appear to be particularly sensitive to Hsc70–4 loss.
2.3 Depletion of Hsc70–4 in the niche induces lamellocyte differentiation through elevating cellular stress in the PSC
Since Hsc70–4 is a chaperone that maintains cellular homeostasis by promoting proper protein folding and preventing protein accumulation (35, 36), and because elevated ROS in the niche can non–cell-autonomously trigger lamellocyte differentiation (, 37–39), we tested whether Hsc70–4 depletion leads to ROS accumulation in PSC cells. We found that silencing Hsc70–4 using the PSC-specific drivers Antp-Gal4 or col-Gal4 led to an upregulation of the stress reporters gstD-GFP and Thor-lacZ (, 39–41), respectively (Figures 3A, B, D, E, quantification in Figures 3C, F). The use of two independent drivers and two distinct ROS reporters strengthens the conclusion that Hsc70–4 is essential for maintaining redox homeostasis in the PSC.
Figure 3
Because the Akt/Foxo pathway has been implicated in oxidative sensing in the niche (39), we next asked whether modulating this pathway could suppress the lamellocyte phenotype in col>Hsc70-4RNAi animals. Indeed, silencing Akt or overexpressing foxo prevented lamellocyte appearance in both the lymph gland and circulation of these animals (Figures 3G–L, G’–L’, quantification in Figures 3M, M’). However, these manipulations did not reduce ROS accumulation in the niche of these larvae (Supplementary Figures S2A–D, quantification in Supplementary Figure S2E), suggesting that Akt/Foxo functions downstream to ROS in this context. This is consistent with previous work in Drosophila and mammalian models showing that ROS functions upstream to the Akt/Foxo pathway (40, 42–44). Interestingly, inhibiting this pathway failed to rescue the smaller PSC size in col>Hsc70-4RNAi (Figures 3G–L, quantification in Figure 3N), implying that while this pathway mediates non–cell-autonomous signals from the niche that regulate progenitor differentiation into lamellocytes, it does not mediate the cell-autonomous role of Hsc70–4 in controlling PSC cell number through non-apoptotic cell death.
2.4 Hsc70–4 depletion in blood cell progenitors causes cell-autonomous lamellocyte differentiation in the lymph gland and their appearance in the circulation
After characterizing the non-cell-autonomous role of Hsc70–4 in suppressing lamellocyte fate in the lymph gland PSC cells, we next investigated whether it also functions within progenitors or differentiated hemocytes in a cell-autonomous manner. To assess its role in progenitors, we employed two progenitor-specific drivers: Tep4-Gal4, which targets core progenitors, and domeMESO-Gal4, which is expressed in both core and distal progenitors (, 45). Interestingly, silencing Hsc70–4 using the Tep4 driver resulted in only limited lamellocyte differentiation in the lymph gland without altering core progenitor size or promoting lamellocyte appearance in the circulation (Figures 4A, B, A’, B’, quantification in Figures 4C, D, C’). In contrast, Hsc70–4 depletion using domeMESO-Gal4 triggered extensive lamellocyte differentiation in the lymph gland, accompanied by a significant reduction in MZ size and the emergence of lamellocytes in the hemolymph (Figures 4E, F, E’, F’, quantification in Figures 4G, H, G’). These results suggest that Hsc70–4 acts cell-autonomously in hemocyte progenitors, particularly within distal progenitors, to restrict their differentiation into lamellocytes. Consistent with findings in the niche, Hsc70–4 silencing in progenitors also reduced crystal cell differentiation, while leaving plasmatocyte differentiation unaffected (Supplementary Figures S3A, B, D, E, quantification in Supplementary Figures S3C, F).
Figure 4
Given that Hsc70–4 knockdown in the niche increased ROS levels, we next asked whether a similar effect occurs in progenitors. Indeed, staining with the ROS-sensitive dye DHE revealed elevated ROS levels in domeMESO>Hsc70-4RNAi medullary zones (Supplementary Figures S3G, H, quantification in Supplementary Figure S3I), suggesting that, similar to the niche, Hsc70–4 silencing in the MZ triggers cellular stress.
We also explored the role of Hsc70–4 in intermediate progenitors using CHIZ-Gal4 (46). Silencing Hsc70–4 in this population led to a significant expansion of intermediate progenitors in the lymph gland, but only weakly promoted lamellocyte differentiation (Figures 4I, J, I’, J’, quantification in Figures 4K, L, K’). Consistent with this limited differentiation, DHE staining revealed no increase in ROS levels in the IZ of CHIZ>Hsc70-4RNAi larvae compared to the control (Supplementary Figures S3M, N, quantification in Supplementary Figure S3O), likely explaining the minimal lamellocyte differentiation in these animals.
2.5 Hsc70–4 depletion in mature blood cells causes their transdifferentiation into lamellocytes in the lymph gland and circulation, and the appearance of melanotic tumors
Finally, we explored whether silencing Hsc70–4 in mature hemocytes would also trigger lamellocyte differentiation. Strikingly, silencing Hsc70–4 using the Hml-Gal4 driver (47) caused disintegration of the anterior lobes of the lymph gland, as validated by Col staining, while the secondary lobes showed pronounced enlargement and differentiation of lamellocytes (Figures 5A-D, quantification in Figures 5C, F, G). Lamellocyte transdifferentiation was also observed in the hemolymph, as evident by the presence of circulating lamellocytes that were also positive for Hml (Figure 5D’, E’, H-J, quantification in Figure 5F’).
Figure 5
Additionally, melanized tumors were observed in Hml>Hsc70-4RNAi larvae (Figure 5K), a phenotype previously reported in Hsc70–4 mutants (). This indicates that this effect specifically results from the lack of Hsc70–4 in mature hemocytes, since its depletion in the PSC or MZ did not cause tumor formation. To confirm that circulating lamellocytes do not originate solely from the lymph gland, we silenced Hsc70–4 using gcm-Gal4, which is specific to circulating hemocytes (48). This also induced lamellocyte differentiation in the circulation, supporting the idea that lamellocytes in Hml>Hsc70-4RNAi larvae originate from both the lymph gland and circulating hemocytes.
Altogether, these findings suggest that Hsc70–4 depletion in mature hemocytes disrupts normal differentiation and induces a robust immune response, mimicking conditions such as immune infestation or certain tumorous states, where lymph gland lobes disintegrate and release cells into circulation, leading to cell aggregation and melanotic mass formation (, 38, 49–52).
3 Discussion
Drosophila melanogaster has been widely utilized in hematopoietic screens to identify novel regulators of blood cell formation and differentiation (, , 53). In a genetic screen aimed at uncovering genes involved in lamellocyte formation within the Drosophila lymph gland, we identified Hsc70-4 (35, 54). While previous studies have reported that Hsc70–4 mutant larvae develop melanotic tumors in their hemolymph (), and that Hsc70–4 plays a role in specifying crystal cell fate in cultured Drosophila cells (, ), its function within the hematopoietic niche and its impact on lamellocyte differentiation in the lymph gland remained unexplored.
In this study, we uncovered a previously unrecognized role for Hsc70–4 in maintaining the size and function of the hematopoietic niche. Our findings indicate that Hsc70–4 knockdown significantly reduces niche cell numbers and induces the differentiation of lamellocytes, which are absent under naive conditions, suggesting that Hsc70–4 plays a non-cell-autonomous role in maintaining hemocyte progenitors. Indeed, lamellocyte differentiation was accompanied by a marked decrease in crystal cell numbers in col>Hsc70-4RNAi larvae, aligning with our previous research and that of others (, 55).
To investigate the cause of niche size reduction in col>Hsc70-4RNAi animals, we assessed the effects of Hsc70–4 depletion on cell division and cell cycle progression. pH3 staining showed no difference in mitotic activity between col>Hsc70-4RNAi and control niches, and overexpression of Myc, a known driver of niche cell proliferation (), failed to restore niche cell numbers. Similarly, promoting mitosis via string (32, 56) overexpression modestly increased PSC size in col>Hsc70-4RNAi>string animals, but PSC cell numbers remained significantly lower than in col>string controls. These results indicate that reduced niche size is not attributable to impaired proliferation or slowed cell cycle progression. Examination of cell death revealed that Hsc70–4 depletion caused increased 7-AAD staining, which labels dying or dead cells. However, neither the apoptotic marker Dcp-1 nor genetic rescue with the apoptosis inhibitor p35 supported apoptosis as the underlying cause. FUCCI analysis revealed an almost complete loss of cells in G1, suggesting that G1-phase cells are particularly vulnerable. Together, these findings indicate that Hsc70–4 maintains niche size primarily by preventing non-apoptotic death of G1-phase niche cells.
Next, we explored the mechanism underlying lamellocyte differentiation in col>Hsc70-4RNAi animals. Since elevated ROS levels in the PSC are known to promote lamellocyte differentiation via a non-cell-autonomous mechanism (, 37–39), we asked whether Hsc70–4 depletion in the PSC triggers ROS accumulation. Using two independent PSC drivers (col-Gal4 and Antp-Gal4) and two stress reporters (gstD-GFP and Thor-lacZ) (39–41), we found that silencing Hsc70–4 in the niche led to elevated ROS levels. These results are consistent with previous reports that Hsc70–4 loss induces a larval stress response (36). Inhibition of the Akt/Foxo pathway, a key mediator of PSC stress signaling (39), suppressed lamellocyte differentiation but did not reduce ROS levels or restore niche size in col>Hsc70-4RNAi animals. These results indicate that Akt/Foxo functions downstream to ROS to mediate non-cell-autonomous lamellocyte differentiation, while the cell-autonomous effect of Hsc70–4 on niche cell survival is independent of this pathway.
Beyond its role in the niche, our data indicate that Hsc70–4 also acts cell-autonomously in hemocyte progenitors to prevent their differentiation into lamellocytes. Silencing Hsc70–4 in MZ progenitors triggered lamellocyte differentiation, underscoring its requirement for progenitor maintenance. Interestingly, this effect was most pronounced when both core and distal progenitors were targeted, whereas silencing in core progenitors alone had little impact. As we reported similar findings in a recent study involving the progenitor maintenance factor Headcase (), this suggests that distal progenitors are more plastic and thus more susceptible to fate changes than core progenitors. Consistent with observations in the niche, Hsc70–4 depletion in progenitors reduced crystal cell differentiation, left plasmatocyte differentiation unaffected, and elevated ROS levels. Although we could not test whether the Akt/Foxo pathway also acts downstream to Hsc70–4 in the MZ due to the compromised survival of domeMESO>Hsc70-4RNAi adults, prior studies suggest that such a rescue would not be expected, as Akt knockdown in progenitors drives lamellocyte differentiation (57), while Foxo overexpression promotes plasmatocyte and crystal cell fates (58). Supporting this, unlike in the niche, Hsc70–4 depletion in progenitors did not induce Thor-lacZ expression (Supplementary Figures S3J, K, quantification in Supplementary Figure S3L), indicating that progenitors respond to Hsc70–4 loss via mechanisms distinct from those in PSC cells.
We further examined the function of Hsc70–4 in intermediate progenitors using CHIZ-Gal4 (46). Knockdown of Hsc70–4 in this population led to a marked expansion of intermediate progenitors but resulted in only minimal lamellocyte differentiation. In line with this, ROS levels remained unchanged in the IZ of CHIZ>Hsc70-4RNAi larvae, which explains the weak differentiation response. Together, these findings highlight a cell-autonomous requirement for Hsc70–4 in progenitor maintenance, with distinct responses between core, distal, and intermediate progenitors, further underscoring the heterogeneity of the progenitor pool.
Finally, we investigated whether Hsc70–4 also regulates lamellocyte fate in mature hemocytes. Our findings show that silencing Hsc70–4 in mature hemocytes triggered a robust immune response, characterized by disintegration of the primary lobes of the lymph glands, lamellocyte transdifferentiation in both the lymph gland and circulation, and the formation of melanotic tumors (, 51, 59). However, we were unable to assess ROS levels due to the premature disintegration of the primary lobes early in development. Nonetheless, it remains possible that ROS signaling is involved in this context, as previous studies have shown that elevated ROS contribute to the immune response and to lamellocyte transdifferentiation following injury (60).
This study expands on the diverse roles previously attributed to Hsc70–4 in Drosophila (–), and demonstrates that Hsc70–4 is essential across all three domains of the larval hematopoietic organ to preserve homeostasis and prevent aberrant differentiation of effector lamellocytes (summarized in Figure 6). Our findings also uncover a critical role for Hsc70–4 in the CZ to suppress premature lymph gland dispersal. Since dispersal typically occurs in response to immune challenges such as wasp infestation (55, 61), it would be interesting to explore whether Hsc70–4 levels are dynamically regulated during such stress conditions. Finally, given that HSPA8, the human ortholog of Hsc70-4, has been implicated as a tumor marker in triple-negative breast cancer (62), further investigation into Hsc70-4’s role in cell fate regulation could provide valuable insights into the cellular mechanisms underlying human carcinogenesis.
Figure 6
4 Materials and methods
4.1 Drosophila stocks and maintenance
The following Drosophila strains were utilized:
w1118 (BDSC#5905), UAS-Hsc70-4RNAi#1 (BDSC #28709), UAS-Hsc70-4RNAi#2 (BDSC#35684), Pcol85-Gal4,UAS-2xEGFP/SM6b (, ), Pcol85-Gal4,UAS-2xEGFP/CyO,GFP; UAS-Hsc70-4RNAi#1/TM6Tb (this study), UAS-Myc (BDSC#9674), UAS-string/CyO,GFP (BDSC#4777, the CyO balancer was changed to CyO,GFP), UAS-p35 (BDSC#5073), UAS-AktRNAi (BDSC#31701), UAS-foxo (BDSC#9575), UAS-FlyFUCCI (BDSC#55122 (31)), gstD-GFP; Antp-Gal4/Tm6Tb (generated from combining gstD-GFP (a gift from Lolitika Mandal (41) with Antp-Gal4 (a gift from Gregory D. Longmore ()), Thor-lacZ (BDSC#9558), domeMESO-Gal4,UAS-2xEGFP/Tm6 (45), Tep4-Gal4 (a gift from Gregory D. Longmore ()), CHIZ-Gal4/CyO,GFP (a gift from Gregory D. Longmore (46)), HmlTurbo-Gal4 (), gcm-gal4 (BDSC#35541), CHIZ-Gal4,UAS-mGFP (Banerjee lab). The flies were maintained on standard cornmeal-yeast media at 25 °C, and all crosses were conducted under the same temperature conditions.
4.2 Antibodies and reagents
The following primary antibodies were used: mouse anti-L1 and mouse anti-P1 (both used at 1:10 concentration and are a gift from István Andó (63)), mouse anti-Col (1:100, a gift from Michèle Crozatier ()), mouse anti-LacZ (1:100, DSHB 40-1a), mouse anti-C1 (HC12F6) (a gift from Tina Trenczek), mouse anti-Hnt (1:20, DSHB 1G9), rabbit anti-Dcp1 (1:100, Cell Signaling Technology, CatNo. 9578), rabbit anti-pH3 (1:200, Cell Signaling Technology CatNo. 3642S). Secondary antibodies were: Goat anti-Rabbit Alexa Fluor 568 (1:1000, Thermo Fisher Scientific, CatNo. A-11011), Goat anti-Mouse Alexa Fluor 568 (1:1000, Thermo Fisher Scientific, CatNo. A-11004), Goat anti-Mouse Alexa Fluor Plus 488 (1:1000, Thermo Fisher Scientific, CatNo. A32723), Rabbit anti-Mouse Alexa Fluor 647 (1:1000, Thermo Fisher Scientific, CatNo. A-21239). Nuclei were visualized with DAPI (Sigma-Aldrich).
4.3 Immunostaining, imaging, and analysis of lymph glands
Lymph glands were dissected and stained following the protocol detailed in Varga et al. (2019) (64). 7-AAD staining (Cayman Chemical, Cat. No. 11397) was performed at a final concentration of 5 µg/mL. Dissected lymph glands were incubated with the dye for 30 minutes on a shaker, washed three times with 1× PBS, and immediately mounted for imaging under the microscope. DHE (Thermo Fisher Scientific, CatNo. D11347) staining was carried out following the protocol of Evans et al. (2014) (65). Sample numbers provided in the figure legends represent data from three independent experiments for each genotype. For each lymph gland, Z-stacks consisting of 10 slices were captured using the 20× objective (except for images in the panels 4M and 4N which were captured using 10× objective) on Zeiss LSM800 and Zeiss LSM980 confocal microscopes. Images are presented as maximum intensity projections of the Z-stacks, with brightness and contrast adjusted using ImageJ/Fiji (US National Institutes of Health, Bethesda, MD, USA) software. All experimental and control images were captured using identical microscope settings. The number of lamellocytes per lymph gland lobe was manually quantified using the multi-point tool in ImageJ/Fiji by counting DAPI-stained nuclei positive for the L1 antibody. Similarly, PSC cell number (PSC size) was manually determined using the same tool by counting DAPI-stained nuclei positive for col>GFP or Col antibody. PSC cells in the G1 (green), S (red), and G2/M (yellow) phases were identified and quantified manually based on their phase-specific colors in the FUCCI system. Additionally, pH3, 7-AAD, Dcp1, and Thor-lacZ positive cells per PSC were manually quantified using the multi-point tool. Crystal cell index was calculated as the ratio of crystal cell number (C1 or Hnt positive cells) to the lymph gland lobe size, measured using the “Analyze > Measure > Area” function in ImageJ/Fiji. The same function was used to measure plasmatocyte (P1 positive), core progenitor (Tep4>GFP positive), MZ (domeMESO>GFP positive), Intermediate progenitor (CHIZ>GFP positive), Mature hemocyte (Hml>GFP) or secondary lobe area after the area was selected using the freehand selection tool in ImageJ/Fiji. For measuring fluorescence intensity of gstD-GFP, Thor-LacZ and DHE markers, the region of interest was selected with the freehand selection tool in ImageJ/Fiji, and mean fluorescence intensity was measured using “Analyze > Measure > Mean Gray Value”. The results were then expressed as fold changes relative to the average fluorescence intensity of the experimental controls.
4.4 Immunostaining, imaging, and quantification of circulating hemocytes
Circulating hemocytes from individual larvae were prepared and stained following the protocol described by Varga et al. (2019) (64). Images were captured using the 10× objective (except for images in the panels 5H-5J which were captured using the 40× objective) on a Zeiss Axio Imager Z1 fluorescence and Zeiss LSM800 microscopes. Nuclei were counted automatically using the ‘cellcounter’ macro in ImageJ/Fiji. Lamellocytes (L1-positive cells) were manually counted using the multi-point tool in ImageJ/Fiji, and their percentage relative to the total number of nuclei was calculated. A minimum of 100 nuclei were analyzed per larva.
4.5 Imaging of larvae
Whole larvae images were captured using a Flexacam C1 camera on a Leica S9D stereomicroscope with 1× magnification.
4.6 Data analysis
All quantitative data analyses and graph generation were performed using GraphPad Prism 8. For comparisons between two groups, a two-tailed unpaired Student’s t-test was applied. For datasets involving more than two groups, analysis of variance (ANOVA) followed by Tukey’s test for multiple comparisons was used. Statistical significance was defined as p < 0.05, with the following thresholds: p ≤ 0.05 (*), p ≤ 0.01 (**), p ≤ 0.001 (***), p ≤ 0.0001 (****), and ns indicating non-significance.
4.7 Data availability
All relevant data are available within the manuscript and its Supporting Information files. We confirm that all data necessary to replicate the results are included.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding authors.
Ethics statement
The manuscript presents research on animals that do not require ethical approval for their study.
Author contributions
BK: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review & editing. EG: Investigation, Writing – review & editing. PV: Writing – review & editing. LMG: Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Writing – review & editing. VH: Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing.
Funding
The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by the National Research, Development and Innovation Office OTKA K-131484 (VH) and the 2022-2.1.1-NL-2022-00008 (National Laboratory of Biotechnology) grants, as well as by a Koret Foundation Catalyst Award (LMG) and a Baxter Foundation Faculty Scholar Award (LMG).
Acknowledgments
We are thankful to István Andó, Éva Kurucz, Michèle Crozatier, Lolitika Mandal, Gregory D. Longmore, Tina Trenczek, and József Mihály for providing us with reagents and Drosophila lines.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2025.1641695/full#supplementary-material
Supplementary Figure 1Silencing Hsc70–4 in the niche reduces crystal cell index with no effect on plasmatocyte numbers in the lymph gland. (A, B) Knocking down Hsc70–4 in the PSC (Pcol85-Gal4,UAS-2xEGFP/+; UAS-Hsc70-4RNAi/+) significantly decreases the crystal cell index (average = 2.6, n = 28) (B), compared to the control (Pcol85-Gal4,UAS-2xEGFP/+) (average = 5.8, n = 12) (A) (blue: nuclei, green: PSC, red: crystal cells). n indicates the number of lymph gland lobes examined. Scale bar: 20 μm. (C) A scatter dot plot showing the crystal cell index quantified from the genotypes in the panels (A, B). Each dot on the graph represents a single lymph gland lobe. Data were analyzed using two-tailed unpaired Student’s t-test, ** p ≤ 0.01. (D, E) Knocking down Hsc70–4 in the PSC (Pcol85-Gal4,UAS-2xEGFP/+; UAS-Hsc70-4RNAi/+) (average = 59.15%, n = 20) (E) has no impact on the percentage of P1-positive (plasmatocyte) area per anterior lobe compared to the control (Pcol85-Gal4,UAS-2xEGFP/+) (average = 60.36%, n = 14) (D) (blue: nuclei, green: PSC, red: plasmatocytes). Scale bar: 20 μm. (F) A scatter dot plot illustrating the percentage of P1 positive (plasmatocyte) area per anterior lobe based on the genotypes presented in the panels (D, E). Each dot on the graph represents a single lymph gland lobe. Data were analyzed using two-tailed unpaired Student’s t-test, ns, non-significant. (G, H) Silencing Hsc70–4 using another PSC-specific driver, Antp-Gal4, causes smaller niche size (outlined by dashed lines, based on Col staining) (gstD-GFP/+; Antp-Gal4/UAS-Hsc70-4RNAi) (n = 12) (H), compared to the control (gstD-GFP/+; Antp-Gal4/+) (n = 20) (G) (blue: nuclei, red: PSC). n indicates the number of lymph gland lobes examined. Scale bar: 20 μm. (I) A scatter dot plot showing PSC cell number in larvae from the genotypes presented in panels (G, H). Each dot on the graph represents a PSC from one lymph gland lobe. Data were analyzed using two-tailed unpaired Student’s t-test, **** p ≤ 0.0001.
Supplementary Figure 2Knocking down the Akt/Foxo pathway does not rescue the increase in ROS in the PSC upon Hsc70–4 silencing. (A, B) Knocking down Hsc70–4 in the PSC (Pcol85-Gal4,UAS-2xEGFP/+; UAS-Hsc70-4RNAi/+) significantly increases ROS levels in the niche (outlined by dashed lines, based on col>GFP expression) as assayed by DHE (n = 7) (B) compared to the control (Pcol85-Gal4,UAS-2xEGFP/+; +/+) (n = 11) (A). (C, D) inhibiting the Akt/Foxo pathway through silencing Akt (Pcol85-Gal4,UAS-2xEGFP/+; UAS-Hsc70-4RNAi/UAS-AktRNAi) (n = 8) (C) or overexpression of foxo (Pcol85-Gal4,UAS-2xEGFP/UAS-foxo; UAS-Hsc70-4RNAi/+) (n = 10) does not rescue the increase in ROS levels in the niche (outlined by dashed lines, based on col>GFP expression) of col>Hsc70-4RNAi larvae. (E) A scatter dot plot showing the mean fluorescence intensity of DHE in the PSC represented in fold change quantified from the genotypes in the panels (A-D). Each dot on the graph represents a PSC from a single lobe. Data were analyzed using ANOVA with Tukey’s test for multiple comparisons, ***p ≤ 0.001, ns, non-significant.
Supplementary Figure 3Silencing Hsc70–4 in the MZ reduces crystal cell index with no effect on plasmatocyte numbers in the lymph gland. (A, B) Knocking down Hsc70–4 in the MZ (+/+; domeMESO-Gal4,UAS-2xEGFP/UAS-Hsc70-4RNAi) significantly decreases the crystal cell index fold change (n = 14) (B), compared to the control (+/+; domeMESO-Gal4,UAS-2xEGFP/+) (n = 8) (A) (blue: nuclei, red: crystal cells). n indicates the number of lymph gland lobes examined. Scale bar: 20 μm. (C) A scatter dot plot showing the crystal cell index represented in fold change quantified from the genotypes in the panels (A, B). Each dot on the graph represents a single lymph gland lobe. Data were analyzed using two-tailed unpaired Student’s t-test, *** p ≤ 0.001. (D, E) Knocking down Hsc70–4 in the MZ (+/+; domeMESO-Gal4,UAS-2xEGFP/UAS-Hsc70-4RNAi) has no impact on the percentage of P1-positive (plasmatocyte) area per anterior lobe (n = 8) (E) compared to the control (+/+; domeMESO-Gal4,UAS-2xEGFP/+) (n = 12) (D) (blue: nuclei, red: plasmatocytes). Scale bar: 20 μm. (F) A scatter dot plot illustrating the percentage of P1 positive (plasmatocyte) area per anterior lobe based on the genotypes presented in the panels (D, E). Each dot on the graph represents a single lymph gland lobe. Data were analyzed using two-tailed unpaired Student’s t-test, ns, non-significant. (G, H) Knocking down Hsc70–4 in the MZ (+/+; domeMESO-Gal4,UAS-2xEGFP/UAS-Hsc70-4RNAi) significantly increases the fold change of DHE fluorescence intensity in the MZ (outlined by dashed lines, based on domeMESO>GFP expression) (n = 16) (H) compared to the control (+/+; domeMESO-Gal4,UAS-2xEGFP/+) (n = 16) (G) (red: DHE). n indicates the number of lymph gland lobes examined. Scale bar: 20 μm. (I) A scatter dot plot showing DHE fluorescence intensity represented in fold change quantified from the genotypes in the panels (G-H). Each dot on the graph represents a single lymph gland lobe. Data were analyzed using two-tailed unpaired Student’s t-test, **** p ≤ 0.0001. (J, K) Knocking down Hsc70–4 in the MZ (+/+; domeMESO-Gal4,UAS-2xEGFP/UAS-Hsc70-4RNAi) does not change Thor-LacZ fluorescence intensity in this zone (outlined by dashed lines, based on domeMESO>GFP expression) (n = 10) (K) compared to the control (+/+; domeMESO-Gal4,UAS-2xEGFP) (n = 9) (J) (red: Thor-lacZ). n indicates the number of lymph gland lobes examined. Scale bar: 20 μm. (L) A scatter dot plot showing DHE fluorescence intensity represented in fold change quantified from the genotypes in the panels (J, K). Each dot on the graph represents a single lymph gland lobe. Data were analyzed using two-tailed unpaired Student’s t-test, ns, non-significant. (M, N) Knocking down Hsc70–4 in the IZ (outlined by dashed lines, based on CHIZ>GFP expression) (CHIZ-Gal4,UAS-mGFP/+; UAS-Hsc70-4RNAi/+) does not increase the fold change of DHE fluorescence intensity in the IZ (n = 18) (N) compared to the control (CHIZ-Gal4,UAS-mGFP/+; +/+) (n = 16) (M) (red: DHE). n indicates the number of lymph gland lobes examined. Scale bar: 20 μm. (O) A scatter dot plot showing DHE fluorescence intensity represented in fold change quantified from the genotypes in the panels (M, N). Each dot on the graph represents a single lymph gland lobe. Data were analyzed using two-tailed unpaired Student’s t-test, ns, non-significant.
References
1
EvansCJHartensteinVBanerjeeU. Thicker than blood: conserved mechanisms in drosophila and vertebrate hematopoiesis. Dev Cell. (2003) 5:673–90. doi: 10.1016/S1534-5807(03)00335-6
2
JungSHEvansCJUemuraCBanerjeeU. The Drosophila lymph gland as a developmental model of hematopoiesis. Development. (2005) 132:2521–33. doi: 10.1242/DEV.01837
3
BanerjeeUGirardJRGoinsLMSpratfordCM. Drosophila as a genetic model for hematopoiesis. Genetics. (2019) 211:367–417. doi: 10.1534/GENETICS.118.300223
4
KharratBCsordásGHontiV. Peeling back the layers of lymph gland structure and regulation. Int J Mol Sci. (2022) 23:7767. doi: 10.3390/IJMS23147767
5
CrozatierMUbedaJMVincentAMeisterM. Cellular immune response to parasitization in drosophila requires the EBF orthologue collier. PloS Biol. (2004) 2:e196. doi: 10.1371/JOURNAL.PBIO.0020196
6
KrzemieńJDuboisLMakkiRMeisterMVincentACrozatierM. Control of blood cell homeostasis in Drosophila larvae by the posterior signalling centre. Nature. (2007) 446:325–8. doi: 10.1038/NATURE05650
7
LebestkyTJungSHBanerjeeU. A Serrate-expressing signaling center controls Drosophila hematopoiesis. Genes Dev. (2003) 17:348. doi: 10.1101/GAD.1052803
8
MandalLMartinez-AgostoJAEvansCJHartensteinVBanerjeeU. A Hedgehog- and Antennapedia-dependent niche maintains Drosophila haematopoietic precursors. Nature. (2007) 446:320–4. doi: 10.1038/NATURE05585
9
CsordásGGáborEHontiV. There and back again: The mechanisms of differentiation and transdifferentiation in Drosophila blood cells. Dev Biol. (2021) 469:135–43. doi: 10.1016/J.YDBIO.2020.10.006
10
RizkiTM. circulatory system and associated cells and tissues. Genet Biol Drosophila. (1978) 2b:397–452.
11
ShresthaRGateffE. Ultrastructure and Cytochemistry of the Cell Types in the Larval Hematopoietic Organs and Hemolymph of Drosophila Melanogaster drosophila/hematopoiesis/blool cells/ultrastructure/cytochemistry. Dev Growth Differ. (1982) 24:65–82. doi: 10.1111/J.1440-169X.1982.00065.X
12
HontiVKuruczÉCsordásGLaurinyeczBMárkusRAndóI. In vivo detection of lamellocytes in Drosophila melanogaster. Immunol Lett. (2009) 126:83–4. doi: 10.1016/J.IMLET.2009.08.004
13
HontiVCsordásGKuruczÉMárkusRAndóI. The cell-mediated immunity of Drosophila melanogaster: hemocyte lineages, immune compartments, microanatomy and regulation. Dev Comp Immunol. (2014) 42:47–56. doi: 10.1016/J.DCI.2013.06.005
14
LetourneauMLaprazFSharmaAVanzoNWaltzerLCrozatierM. Drosophila hematopoiesis under normal conditions and in response to immune stress. FEBS Lett. (2016) 590:4034–51. doi: 10.1002/1873-3468.12327
15
RizkiTMRizkiRM. Lamellocyte differentiation in Drosophila larvae parasitized by Leptopilina. Dev Comp Immunol. (1992) 16:103–10. doi: 10.1016/0145-305X(92)90011-Z
16
StofankoMKwonSYBadenhorstP. Lineage tracing of lamellocytes demonstrates Drosophila macrophage plasticity. PloS One. (2010) 5:e14051. doi: 10.1371/journal.pone.0014051
17
Avet-RochexABoyerKPoleselloCGobertVOsmanDRochFet al. An in vivo RNA interference screen identifies gene networks controlling Drosophila melanogasterblood cell homeostasis. BMC Dev Biol. (2010) 10:1–15. doi: 10.1186/1471-213X-10-65
18
ZettervallCJAnderlIWilliamsMJPalmerRKuruczEAndoIet al. A directed screen for genes involved in Drosophila blood cell activation. Proc Natl Acad Sci U.S.A. (2004) 101:14192–7. doi: 10.1073/PNAS.0403789101
19
TowerJ. Heat shock proteins and Drosophila aging. Exp Gerontol. (2011) 46:355–62. doi: 10.1016/j.exger.2010.09.002
20
MorrowGHeikkilaJJTanguayRM. Differences in the chaperone-like activities of the four main small heat shock proteins of Drosophila melanogaster. Cell Stress Chaperones. (2006) 11:51. doi: 10.1379/CSC-166.1
21
BronkPWennigerJJDawson-ScullyKGuoXHongSAtwoodHLet al. Drosophila Hsc70–4 is critical for neurotransmitter exocytosis. vivo Neuron. (2001) 30:475–88. doi: 10.1016/S0896-6273(01)00292-6
22
YuJLanXChenXYuCXuYLiuYet al. Protein synthesis and degradation are essential to regulate germline stem cell homeostasis in Drosophila testes. Development. (2016) 143:2930–45. doi: 10.1242/dev.134247
23
KumarATiwariAK. Molecular chaperone Hsp70 and its constitutively active form Hsc70 play an indispensable role during eye development of Drosophila melanogaster. Mol Neurobiol. (2018) 55:4345–61. doi: 10.1007/s12035-017-0650-z
24
BraunALemaitreBLanotRZacharyDMeisterM. Drosophila immunity: analysis of larval hemocytes by P-element-mediated enhancer trap. Genetics. (1997) 147:623–34. doi: 10.1093/genetics/147.2.623
25
DyerJODuttaAGogolMWeakeVMDialynasGWuXet al. Myeloid leukemia factor acts in a chaperone complex to regulate transcription factor stability and gene expression. J Mol Biol. (2017) 429:2093–107. doi: 10.1016/j.jmb.2016.10.026
26
MillerMChenAGobertVAugéBBeauMBurlet-SchiltzOet al. Control of RUNX-induced repression of Notch signaling by MLF and its partner DnaJ-1 during Drosophila hematopoiesis. PloS Genet. (2017) 13:e1006932. doi: 10.1371/journal.pgen.1006932
27
KharratBGáborEVirágNSinkaRJankovicsFKristóIet al. Dual role for Headcase in hemocyte progenitor fate determination in Drosophila melanogaster. PloS Genet. (2024) 20:e1011448. doi: 10.1371/journal.pgen.1011448
28
KrzemienJOyallonJCrozatierMVincentA. Hematopoietic progenitors and hemocyte lineages in the Drosophila lymph gland. Dev Biol. (2010) 346:310–9. doi: 10.1016/J.YDBIO.2010.08.003
29
PennetierDOyallonJMorin-PoulardIDejeanSVincentACrozatierM. Size control of the Drosophila hematopoietic niche by bone morphogenetic protein signaling reveals parallels with mammals. Proc Natl Acad Sci U.S.A. (2012) 109:3389–94. doi: 10.1073/PNAS.1109407109/-/DCSUPPLEMENTAL
30
KimJ-YJeongHSChungTKimMLeeJHJungWHet al. The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67. Oncotarget. (2017) 8:65064. doi: 10.18632/oncotarget.17775
31
ZielkeNKorzeliusJvan StraatenMBenderKSchuhknechtGFPDuttaDet al. Fly-FUCCI: A versatile tool for studying cell proliferation in complex tissues. Cell Rep. (2014) 7:588–98. doi: 10.1016/j.celrep.2014.03.020
32
EdgarBALehmanDAO’FarrellPH. Transcriptional regulation of string (cdc25): a link between developmental programming and the cell cycle. Development. (1994) 120:3131–43. doi: 10.1242/dev.120.11.3131
33
EdgarBAO’FarrellPH. The three postblastoderm cell cycles of Drosophila embryogenesis are regulated in G2 by string. Cell. (1990) 62:469–80. doi: 10.1016/0092-8674(90)90012-4
34
GillJEJotzMMYoungSGModestEJSenguptaSK. 7-Amino-actinomycin D as a cytochemical probe. I. Spectral properties. J Histochem Cytochem. (1975) 23:793–9. doi: 10.1177/23.11.1194669
35
RubinDMMehtaADZhuJShohamSChenXWellsQRet al. Genomic structure and sequence analysis of Drosophila melanogaster HSC70 genes. Gene. (1993) 128:155–63. doi: 10.1016/0378-1119(93)90558-K
36
ElefantFPalterKB. Tissue-specific expression of dominant negative mutant Drosophila HSC70 causes developmental defects and lethality. Mol Biol Cell. (1999) 10:2101–17. doi: 10.1091/mbc.10.7.2101
37
KaurHSharmaSKMandalSMandalL. Lar maintains the homeostasis of the hematopoietic organ in Drosophila by regulating insulin signaling in the niche. Development. (2019) 146. doi: 10.1242/DEV.178202
38
LouradourISharmaAMorin-PoulardILetourneauMVincentACrozatierMet al. Reactive oxygen species-dependent Toll/NF-κB activation in the Drosophila hematopoietic niche confers resistance to wasp parasitism. Elife. (2017) 6:e25496. doi: 10.7554/eLife.25496
39
SinenkoSAShimJBanerjeeU. Oxidative stress in the haematopoietic niche regulates the cellular immune response in Drosophila. EMBO Rep. (2012) 13:83. doi: 10.1038/EMBOR.2011.223
40
JüngerMARintelenFStockerHWassermanJDVéghMRadimerskiTet al. The Drosophila Forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J Biol. (2003) 2:20. doi: 10.1186/1475-4924-2-20
41
SykiotisGPBohmannD. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev Cell. (2008) 14:76. doi: 10.1016/J.DEVCEL.2007.12.002
42
KlotzL-OSánchez-RamosCPrieto-ArroyoIUrbánekPSteinbrennerHMonsalveM. Redox regulation of FoxO transcription factors. Redox Biol. (2015) 6:51–72. doi: 10.1016/j.redox.2015.06.019
43
Rodriguez-ColmanMJDansenTBBurgeringBMT. FOXO transcription factors as mediators of stress adaptation. Nat Rev Mol Cell Biol. (2024) 25:46–64. doi: 10.1038/s41580-023-00649-0
44
ChaeH-DBroxmeyerHE. SIRT1 regulates PTEN/akt/FOXO1 pathway to trigger ROS-induced apoptosis in mouse embryonic stem cells. Blood. (2010) 116:1610. doi: 10.1182/blood.V116.21.1610.1610
45
OyallonJVanzoNKrzemieńJMorin-PoulardIVincentACrozatierM. Two independent functions of collier/early B cell factor in the control of drosophila blood cell homeostasis. PloS One. (2016) 11:e0148978. doi: 10.1371/JOURNAL.PONE.0148978
46
SpratfordCMGoinsLMChiFGirardJRMaciasSNHoVWet al. Intermediate progenitor cells provide a transition between hematopoietic progenitors and their differentiated descendants. Dev (Cambridge). (2021) 148. doi: 10.1242/DEV.200216
47
GotoAKadowakiTKitagawaY. Drosophila hemolectin gene is expressed in embryonic and larval hemocytes and its knock down causes bleeding defects. Dev Biol. (2003) 264:582–91. doi: 10.1016/J.YDBIO.2003.06.001
48
KhadilkarRJRodriguesDMoteRDSinhaARKulkarniVMagadiSSet al. ARF1–GTP regulates Asrij to provide endocytic control of Drosophila blood cell homeostasis. Proc Natl Acad Sci. (2014) 111:4898–903. doi: 10.1073/pnas.1303559111
49
AnderlIVesalaLIhalainenTOVanha-ahoLMAndóIRämetMet al. Transdifferentiation and Proliferation in Two Distinct Hemocyte Lineages in Drosophila melanogaster Larvae after Wasp Infection. PloS Pathog. (2016) 12:e1005746. doi: 10.1371/JOURNAL.PPAT.1005746
50
RizkiRMRizkiTM. Cell interactions in the differentiation of a melanotic tumor in Drosophila. Differentiation. (1979) 12:167–78. doi: 10.1111/J.1432-0436.1979.TB01002.X
51
BarigozziC. Melanotic tumors in DROSOPHILA. J Cell Comp Physiol. (1958) 52:371–81. doi: 10.1002/JCP.1030520417
52
RodriguesDRenaudYVijayraghavanKWaltzerLInamdarMS. Differential activation of JAK-STAT signaling reveals functional compartmentalization in Drosophila blood progenitors. Elife. (2021) 10:1–77. doi: 10.7554/ELIFE.61409
53
EvansCJOlsonJMMondalBCKandimallaPAbbasiAAbdusamadMMet al. A functional genomics screen identifying blood cell development genes in Drosophila by undergraduates participating in a course-based research experience. G3. (2021) 11:jkaa028. doi: 10.1093/g3journal/jkaa028
54
PerkinsLADoctorJSZhangKStinsonLPerrimonNCraigEA. Molecular and developmental characterization of the heat shock cognate 4 gene of Drosophila melanogaster. Mol Cell Biol. (1990) 10:3232–8. doi: 10.1128/mcb.10.6.3232-3238.1990
55
KrzemienJCrozatierMVincentA. Ontogeny of the Drosophila larval hematopoietic organ, hemocyte homeostasis and the dedicated cellular immune response to parasitism. Int J Dev Biol. (2010) 54:1117–25. doi: 10.1387/ijdb.093053jk
56
BouldinCMKimelmanD. Cdc25 and the importance of G2 control: insights from developmental biology. Cell Cycle. (2014) 13:2165. doi: 10.4161/cc.29537
57
BenmimounBPoleselloCWaltzerLHaenlinM. Dual role for Insulin/TOR signaling in the control of hematopoietic progenitor maintenance in Drosophila. Development. (2012) 139:1713–7. doi: 10.1242/DEV.080259
58
Owusu-AnsahEBanerjeeU. Reactive Oxygen Species prime Drosophila haematopoietic progenitors for differentiation. Nature. (2009) 461:537. doi: 10.1038/NATURE08313
59
RizkiMTM. Melanotic tumor formation in drosophila. J Morphol. (1960) 106:147–57. doi: 10.1002/JMOR.1051060203
60
EvansCJLiuTGirardJRBanerjeeU. Injury-induced inflammatory signaling and hematopoiesis in Drosophila. Proc Natl Acad Sci. (2022) 119:e2119109119. doi: 10.1073/pnas.2119109119
61
SorrentinoRPCartonYGovindS. Cellular immune response to parasite infection in the Drosophila lymph gland is developmentally regulated. Dev Biol. (2002) 243:65–80. doi: 10.1006/DBIO.2001.0542
62
YingBXuWNieYLiY. HSPA8 is a new biomarker of triple negative breast cancer related to prognosis and immune infiltration. Dis Markers. (2022) 2022:8446857. doi: 10.1155/2022/8446857
63
KuruczÉVácziBMárkusRLaurinyeczBVilmosPZsámbokiJet al. Definition of Drosophila hemocyte subsets by cell-type specific antigens. Acta Biol Hung. (2007) 58:95–111. doi: 10.1556/ABiol.58.2007.Suppl.8
64
VargaGIBCsordásGCinegeGJankovicsFSinkaRKuruczÉet al. Headcase is a repressor of lamellocyte fate in drosophila melanogaster. Genes (Basel). (2019) 10. doi: 10.3390/GENES10030173
65
EvansCJLiuTBanerjeeU. Drosophila hematopoiesis: markers and methods for molecular genetic analysis. Methods. (2014) 68:242–51. doi: 10.1016/j.ymeth.2014.02.038
Summary
Keywords
Hsc70-4, hematopoiesis, lamellocytes, blood cell, Drosophila
Citation
Kharrat B, Gábor E, Vilmos P, Goins LM and Honti V (2025) A novel role for Hsc70–4 in blood cell differentiation in Drosophila. Front. Immunol. 16:1641695. doi: 10.3389/fimmu.2025.1641695
Received
05 June 2025
Accepted
26 September 2025
Published
08 October 2025
Volume
16 - 2025
Edited by
Andrew Rowley, Swansea University, United Kingdom
Reviewed by
Bumsik Cho, University of Pennsylvania, United States
Fangzhou Luo, Northeast Forestry University, China
Updates
Copyright
© 2025 Kharrat, Gábor, Vilmos, Goins and Honti.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lauren M. Goins, lgoins@stanford.edu; Viktor Honti, honti.viktor@brc.hu
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.